AIDS Vaccine Study Comparing Immunogenicity and Safety of 3 Doses of Lipopeptides Versus Placebo in Non Infected HIV Volunteers

NCT00121758 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

156

Enrollment

OTHER_GOV

Sponsor class

Conditions

HIV Infections

Interventions

BIOLOGICAL: LIPO-5

Sponsor

French National Agency for Research on AIDS and Viral Hepatitis

Collaborators

[object Object]